Related Experiment Video
Updated: Jun 2, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke
Xu Cui1, Michael Chopp, Alex Zacharek
1Department of Neurology, Henry Ford Hospital, Detroit, MI 48202, USA.
Abstract:
We investigated the changes and the molecular mechanisms of cerebral vascular damage after stroke in type-2 diabetic (T2DM) mice. Adult male db/db T2DM and wild-type (WT) mice were subjected to transient middle cerebral artery occlusion (MCAo) and sacrificed 24 hours after MCAo. T2DM-mice exhibited significantly increased blood glucose, brain hemorrhagic rate, mortality and cerebrovascular density, but decreased cerebrovascular diameter, arteriolar density and arterial mural cell numbers in the ischemic brain compared with WT mice. The hemorrhagic rate was significantly correlated with the mortality (r = 0.85). T2DM-mice also exhibited increased blood-brain barrier leakage and concomitantly, increased Angiopoietin2, but decreased Angiopoietin1, Tie2 and tight junction protein expression in the ischemic brain. Angiopoietin1 gene expression also significantly decreased in the common carotid artery (CCA) in T2DM-mice compared with WT mice after stroke. To further test the effects of T2DM on cerebrovascular damage, we performed in vitro studies. The capillary-like tube formation of primary cultured mouse brain endothelial cells (MBECs) significantly increased, but artery cell migration in the primary CCA cultures significantly decreased both in Sham and MCAo T2DM-mice compared with the WT mice. Angiopoietin1 treatment significantly increased artery cell migration in T2DM-CCA after MCAo. Tie2-FC, a neutralized Tie2 antibody, significantly decreased artery cell migration in WT-CCA after MCAo. Therefore, decreased Angiopoietin1/Tie2 and increased Angiopoietin2 expression may contribute to diabetes-induced vascular damage after stroke.
Insights
Type-2 diabetes exacerbates stroke-induced brain vascular damage by increasing hemorrhage and blood-brain barrier leakage. This is linked to altered Angiopoietin-Tie2 signaling, impacting cerebrovascular integrity.
Area of Science:
- Neuroscience
- Vascular Biology
- Metabolic Disorders
Background:
- Type-2 diabetes mellitus (T2DM) is a growing global health concern.
- Stroke is a leading cause of death and disability worldwide.
- The impact of T2DM on cerebrovascular damage following stroke remains incompletely understood.
Purpose of the Study:
- To investigate the effects of T2DM on cerebral vascular damage after stroke.
- To elucidate the molecular mechanisms underlying diabetes-induced cerebrovascular injury.
Main Methods:
- Transient middle cerebral artery occlusion (MCAo) model in type-2 diabetic (db/db) and wild-type (WT) mice.
- Assessment of neurological deficits, mortality, hemorrhagic rate, and cerebrovascular parameters.
- Analysis of blood-brain barrier integrity and expression of Angiopoietin-Tie2 signaling pathway components.
- In vitro studies using primary mouse brain endothelial cells (MBECs) and common carotid artery (CCA) cultures.
Main Results:
- T2DM mice exhibited increased hyperglycemia, hemorrhagic rate, mortality, and cerebrovascular density post-stroke.
- Reduced cerebrovascular diameter, arteriolar density, and arterial mural cell numbers were observed in T2DM mice.
- Increased blood-brain barrier leakage, elevated Angiopoietin2, and decreased Angiopoietin1 and Tie2 expression in the ischemic brain.
- In vitro studies showed altered endothelial cell function and impaired artery cell migration in T2DM models.
Conclusions:
- T2DM significantly worsens cerebral vascular damage after stroke.
- Decreased Angiopoietin1/Tie2 signaling and increased Angiopoietin2 contribute to diabetes-induced cerebrovascular injury.
- These findings highlight potential therapeutic targets for stroke in diabetic patients.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Regulation of Angiogenesis and Blood Supply
Ischemic Stroke ll: Pathophysiology
Diabetic Retinopathy
Hemorrhagic Stroke ll: Pathophysiology